Zogenix reported $-53870000 in Operating Profit for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Acadia Pharmaceuticals ACAD:US $ -15.3M 28.41M
Acura Pharmaceuticals ACUR:US -300000 154K
Adamas Pharmaceuticals ADMS:US -5636000 3.52M
Aerie Pharmaceuticals AERI:US $ -32.37M 0.87M
Alnylam Pharmaceuticals ALNY:US $ -181.68M 35.52M
Arena Pharmaceuticals ARNA:US $ -194.48M 50.09M
AstraZeneca AZN:LN -1674000000 2.8B
Becton, Dickinson and BDX:US $ 495M 133M
Biocryst Pharmaceuticals BCRX:US $ -44.58M 15M
Biogen BIIB:US $ 794M 308.3M
Cardinal Health CAH:US 405M 256M
Esperion Therapeutics ESPR:US $ -55745000 23.21M
Flexion Therapeutics FLXN:US $ -23658000 6.78M
GlaxoSmithKline GSK:LN 1.94B 263M
Gw Pharmaceuticals GWPH:US $ -21.03M 1.78M
Heron Therapeutics HRTX:US $ -51.71M 8.76M
Intra Cellular Therapies ITCI:US $ -77.32M 8.18M
Johnson & Johnson JNJ:US $ 3849M 2813M
Marinus Pharmaceuticals MRNS:US $ -19.17M 4.32M
Merk MRK:US $ 4826M 3212M
Nektar Therapeutics NKTR:US $ -113.6M 3.39M
Neurocrine Biosciences NBIX:US $ 44.5M 18.3M
Pfizer PFE:US $ 7647M 1733M
Revance Therapeutics RVNC:US $ -72723000 2.39M
Sarepta Therapeutics SRPT:US $ -38.95M 128.63M
Teva Pharmaceutical TEVA:IT 623M 41M
Zogenix ZGNX:US $ -53.87M 1.56M